ヒトの臓がんにおけるコアシグナル伝達経路は,グローバルゲノム解析によって明らかになりました
Siân Jones1, Xiaosong Zhang, D Williams Parsons
1Sol Goldman Pancreatic Cancer Research Center, Ludwig Center and Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.
Science (New York, N.Y.)
|September 6, 2008
まとめ
臓がんの研究は,腫瘍ごとに平均63の遺伝子変異を明らかにし,主に点変異です. これらの突然変異は,臓がんの発症を理解するために不可欠な12の核細胞経路を乱します.
科学分野:
- 腫瘍学 腫瘍学
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- 臓がんは治療の選択肢が限られており,その病原性をより深く理解する必要がある.
- 総合的な遺伝子分析は,新しい治療目標と洞察を特定するために不可欠です.
研究 の 目的:
- 臓がんの包括的な遺伝分析を行い,主要な変異と影響された経路を特定します.
- 臓腫瘍発生の遺伝的根拠を理解し,潜在的な治療戦略を特定する.
主な方法:
- 23,219のトランスクリプト (20,661のタンパク質をコードする遺伝子) を24の臓がんサンプルでシーケンシングした.
- シングル・ヌクレオチド・ポリモルフィズム (SNP) 探査機を用いたマイクロアレイ分析により,同同同位体の欠失と増幅を検出する.
- 腫瘍トランスクリプトームを分析するための次世代合成によるシーケンシング技術.
主要な成果:
- 臓がんは平均して63の遺伝子変異,主に点変異を呈する.
- 腫瘍の67~100%で遺伝的に変化した12の核細胞信号伝達経路とプロセスを特定しました.
- トランスクリプトーム解析は,これらの変化した経路が臓がんにおける重要性を確認した.
結論:
- コア経路における遺伝的変異は,臓がんの発症に不可欠である.
- 徹底したゲノム分析により,腫瘍発生を誘発する重要な制御不良の経路が明らかになった.
- これらの遺伝的障害を理解することで,臓がん治療の改善の可能性が生まれます.
関連する概念動画
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...